Synthesis and Preclinical Evaluation of 68 Ga-Labeled Radiotracers for Monitoring PD-L1 Expression in Tumors
Journal of Medicinal Chemistry · 23.04.2026 · 69 (8) · 9125-9141
DOI: 10.1021/acs.jmedchem.5c03587 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, online erschienen am 10.04.2026. Verfasst von Bo Zhou und 7 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory for Experimental Teratology of the Ministry of Education and Research Center for Experimental Nuclear Medicine, School of Basic Medica…. Hauptthemen laut MEDLINE: B7-H1 Antigen, Gallium Radioisotopes, Radiopharmaceuticals. Die Arbeit nennt 58 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Shandong Province, National Science and Technology Major Project.
Abstract (Originalsprache)
Programmed death-ligand 1 (PD-L1) plays a crucial role in tumor immune evasion, making it an important biomarker and a validated target for cancer immunotherapy. In this study, we designed, synthesized, and preclinically evaluated a series of novel PD-L1-targeted radiotracers based on a phenoxymethyl-biphenyl scaffold. Our design strategy was to incorporate different functional amino acid residues and flexible linkers between the phenoxymethyl-biphenyl scaffold and the DOTA chelator. Among the six radiotracers, [ 68 Ga]Ga-PEG-PRO-ZB exhibited high stability, strong binding affinity to PD-L1 ( K D = 19.3 ± 0.6 nM), and low nonspecific uptake. Micro-PET/CT imaging confirmed its ability to detect PD-L1 expression in multiple tumor models. Notably, [ 68 Ga]Ga-PEG-PRO-ZB also enabled the dynamic monitoring of PD-L1 expression following immunotherapy. These results demonstrate that [ 68 Ga]Ga-PEG-PRO-ZB can effectively visualize PD-L1 expression in vivo, offering valuable insights into the rational design and optimization of small-molecule based PD-L1 radiotracers.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Key Laboratory for Experimental Teratology of the Ministry of Education and Research Center for Experimental Nuclear Medicine, School of Basic Medical Sciences, Shandong University, Jinan 250012, Shandong, China.
- Department of Radiation Oncology, Qilu Hospital of Shandong University, Jinan 250012, Shandong, China.
- Department of Nuclear Medicine, Zibo Municipal Hospital, Zibo 255400, Shandong, China.
- Department of Nuclear Medicine, 960th Hospital of PLA, Jinan 250033, Shandong, China.
- Department of Nuclear Medicine, The Second Hospital of Jilin University, Changchun 130041, Jilin, China.
ORCID-Profile: Feng Gao
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Shandong Province
- National Science and Technology Major Project
Zitieren
APA
Zhou, B., Zhang, X., Fang, K., Pan, Y., Shang, X., Li, M., Zhao, Y., & Gao, F. (2026). Synthesis and Preclinical Evaluation of 68 Ga-Labeled Radiotracers for Monitoring PD-L1 Expression in Tumors. Journal of Medicinal Chemistry, 69(8), 9125-9141. https://doi.org/10.1021/acs.jmedchem.5c03587
Vancouver
Zhou B, Zhang X, Fang K, Pan Y, Shang X, Li M, et al. Synthesis and Preclinical Evaluation of 68 Ga-Labeled Radiotracers for Monitoring PD-L1 Expression in Tumors. Journal of Medicinal Chemistry. 2026;69(8):9125-9141. doi:10.1021/acs.jmedchem.5c03587
BibTeX
@article{Zhou2026,
author = {Zhou, Bo and Zhang, Xiaoli and Fang, Kexia and Pan, Yuan and Shang, Xue and Li, Min and Zhao, Yinlong and Gao, Feng},
title = {Synthesis and Preclinical Evaluation of 68 Ga-Labeled Radiotracers for Monitoring PD-L1 Expression in Tumors},
journal = {Journal of Medicinal Chemistry},
year = {2026},
volume = {69},
number = {8},
pages = {9125--9141},
doi = {10.1021/acs.jmedchem.5c03587}
}
EUVIMED